ZA796374B - 2-substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)indoles - Google Patents

2-substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)indoles

Info

Publication number
ZA796374B
ZA796374B ZA00796374A ZA796374A ZA796374B ZA 796374 B ZA796374 B ZA 796374B ZA 00796374 A ZA00796374 A ZA 00796374A ZA 796374 A ZA796374 A ZA 796374A ZA 796374 B ZA796374 B ZA 796374B
Authority
ZA
South Africa
Prior art keywords
indoles
pyrido
hexahydro
trans
aryl
Prior art date
Application number
ZA00796374A
Other languages
English (en)
Inventor
Willard Mckowan Welch
Mckowan Welch Willard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA796374B publication Critical patent/ZA796374B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
ZA00796374A 1979-01-23 1979-11-23 2-substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)indoles ZA796374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (1)

Publication Number Publication Date
ZA796374B true ZA796374B (en) 1980-11-26

Family

ID=21717248

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00796374A ZA796374B (en) 1979-01-23 1979-11-23 2-substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)indoles

Country Status (34)

Country Link
US (1) US4224329A (el)
JP (4) JPS55100386A (el)
KR (1) KR830001932A (el)
AR (1) AR231291A1 (el)
AT (1) AT376674B (el)
AU (1) AU521986B2 (el)
BE (1) BE881283A (el)
CA (1) CA1144168A (el)
CH (2) CH651040A5 (el)
CS (4) CS221806B2 (el)
DD (2) DD149071A5 (el)
DE (1) DE3002367A1 (el)
DK (1) DK25580A (el)
EG (1) EG14767A (el)
FI (1) FI800179A (el)
FR (3) FR2447379A1 (el)
GB (1) GB2041925B (el)
GR (1) GR73567B (el)
HU (3) HU188201B (el)
IE (1) IE49500B1 (el)
IL (1) IL59189A (el)
IN (1) IN153300B (el)
IT (1) IT1149927B (el)
LU (1) LU82105A1 (el)
NL (1) NL8000385A (el)
NO (2) NO151895C (el)
NZ (3) NZ192175A (el)
PH (4) PH15736A (el)
PL (4) PL126532B1 (el)
PT (1) PT70724A (el)
SE (3) SE441358B (el)
SU (3) SU1168094A3 (el)
YU (2) YU269379A (el)
ZA (1) ZA796374B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
CZ294532B6 (cs) * 1998-12-21 2005-01-12 Janssen Pharmaceutica N. V. Benzisoxazoly a fenony jako alfa2-antagonisté, způsob jejich přípravy a použití a farmaceutický prostředek
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (el) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
AR207799A1 (es) * 1974-04-01 1976-10-29 Pfizer Procedimiento para preparar azaciclo(3,4-a)-n-fenilindoles-2-substituidos
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
HU188201B (en) 1986-03-28
PL120774B1 (en) 1982-03-31
CS221806B2 (en) 1983-04-29
DD149071A5 (de) 1981-06-24
KR830001932A (ko) 1983-05-19
SU1080746A3 (ru) 1984-03-15
IT8019373A0 (it) 1980-01-22
FR2453175B1 (el) 1983-07-29
US4224329A (en) 1980-09-23
DK25580A (da) 1980-07-24
SE8404554D0 (sv) 1984-09-11
FI800179A (fi) 1980-07-24
HU184712B (en) 1984-10-29
IE800121L (en) 1980-07-23
PL221248A1 (el) 1980-12-01
JPS5855151B2 (ja) 1983-12-08
PL126867B1 (en) 1983-09-30
BE881283A (fr) 1980-07-22
IN153300B (el) 1984-06-30
NL8000385A (nl) 1980-07-25
FR2447379B1 (el) 1983-08-19
YU269379A (en) 1984-04-30
NZ192175A (en) 1984-05-31
PH15072A (en) 1982-06-03
JPS5636486A (en) 1981-04-09
EG14767A (en) 1985-12-31
PL126532B1 (en) 1983-08-31
SE8404555D0 (sv) 1984-09-11
GB2041925B (en) 1982-10-20
FR2453174B1 (el) 1983-07-29
SU1168094A3 (ru) 1985-07-15
JPS5740151B2 (el) 1982-08-25
PT70724A (en) 1980-02-01
CS221808B2 (en) 1983-04-29
PL126032B1 (en) 1983-07-30
NZ197581A (en) 1984-05-31
AU5476580A (en) 1980-07-31
FR2447379A1 (fr) 1980-08-22
CH648314A5 (fr) 1985-03-15
PH15086A (en) 1982-07-02
NO151895B (no) 1985-03-18
PH15736A (en) 1983-03-18
JPS5636487A (en) 1981-04-09
AR231291A1 (es) 1984-10-31
CA1144168A (en) 1983-04-05
SE8404554L (sv) 1984-09-11
IL59189A (en) 1984-01-31
ATA33380A (de) 1984-05-15
CH651040A5 (fr) 1985-08-30
JPS55100386A (en) 1980-07-31
CS221809B2 (en) 1983-04-29
JPS5636475A (en) 1981-04-09
AT376674B (de) 1984-12-27
SE8000329L (sv) 1980-07-24
YU242183A (en) 1984-06-30
HU189174B (en) 1986-06-30
FR2453174A1 (fr) 1980-10-31
GB2041925A (en) 1980-09-17
AU521986B2 (en) 1982-05-13
CS221807B2 (en) 1983-04-29
SE441358B (sv) 1985-09-30
GR73567B (el) 1984-03-16
IL59189A0 (en) 1980-05-30
NO151895C (no) 1985-06-26
NZ197582A (en) 1984-05-31
DD156369A5 (de) 1982-08-18
PH17773A (en) 1984-12-11
IT1149927B (it) 1986-12-10
IE49500B1 (en) 1985-10-16
LU82105A1 (fr) 1980-08-08
NO794317L (no) 1980-07-24
NO843041L (no) 1980-07-24
SE8404555L (sv) 1984-09-11
SU1333239A3 (ru) 1987-08-23
DE3002367A1 (de) 1980-07-24
FR2453175A1 (fr) 1980-10-31

Similar Documents

Publication Publication Date Title
GB2064520B (en) A-aryl-1h-1,2,4-triazole-1-ethanols
HK89884A (en) 3-(1-imidazolylalkyl)indoles
GB2041925B (en) 2-substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido (4,3-b)indoles
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
IL59829A0 (en) Substituted 9,10-anthracene-bishydrazones
NZ194529A (en) 9,10-dihydro-1h, 4h-pyrazolo (4,3-b)(1,5)benzodiazepin-10-ones
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
PH15062A (en) 1-hydroxyalkanamine pyrano (3,4-b)indole derivative
GB2061275B (en) Substituted-s-triazolo(4,3-b)pyridazines
PH14613A (en) 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)-benzodiazepine-6-ones
PH13756A (en) Trans-5-aryl-2,3,4,4a,5,9b-hexahydro-in pyrido(4,3-b)indoles
GB2044770B (en) 24,24 - difluoro- 25 - hydroxycholecalciferol
ZA807494B (en) 2,3-indoledione derivatives
CS528780A2 (en) Zpusob vyroby substituovanych pyrido-(1,2-a)pyrimidinu
NZ193666A (en) 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles
GB2030133B (en) Tetrahydrothiopyrano (2,3-b) indole derivatives
GB2055815B (en) Indoles
IL61535A0 (en) 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carboxamides
PH16593A (en) 11-piperazinyl 5h-pyrrolo(1,2-b)(1,2,5)benzotriazepines
CS340780A2 (en) Zpusob vyroby pyrazolo (1,5 c) chinazolinovych derivatu
IL75705A (en) 1,2,5-thiadiazole-1-oxides
ZA804183B (en) 1,2,4-thiadiazolyloxyphenylureas
JPS6485961A (en) 3,5-cyclovitamine derivative
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
CS515881A2 (en) Zpusob pripravy oktahydropyrazolo(3,4 g) chinolinu